These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325 [TBL] [Abstract][Full Text] [Related]
8. miR-195-5p alleviates acute kidney injury through repression of inflammation and oxidative stress by targeting vascular endothelial growth factor A. Xu Y; Jiang W; Zhong L; Li H; Bai L; Chen X; Lin Y; Zheng D Aging (Albany NY); 2020 Jun; 12(11):10235-10245. PubMed ID: 32492657 [TBL] [Abstract][Full Text] [Related]
9. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability. Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035 [TBL] [Abstract][Full Text] [Related]
10. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis. Picken M; Long J; Williamson GA; Polichnowski AJ Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia as a key player in the AKI-to-CKD transition. Tanaka S; Tanaka T; Nangaku M Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978 [TBL] [Abstract][Full Text] [Related]